FutureChem Co.,Ltd (220100.KQ)
KRW 20400.0
(3.61%)
KRW 20400.0
(3.61%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 8.91 Billion KRW | -51.62% |
| 2022 | 18.43 Billion KRW | -23.9% |
| 2021 | 24.22 Billion KRW | -37.64% |
| 2020 | 38.84 Billion KRW | -24.94% |
| 2019 | 51.74 Billion KRW | 9.69% |
| 2018 | 47.17 Billion KRW | 436.11% |
| 2017 | 8.79 Billion KRW | 458.64% |
| 2016 | 1.57 Billion KRW | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 8.37 Billion KRW | -7.09% |
| 2024 Q1 | 9.01 Billion KRW | 1.04% |
| 2023 FY | 8.91 Billion KRW | -51.62% |
| 2023 Q2 | 7.47 Billion KRW | -15.65% |
| 2023 Q3 | 8.43 Billion KRW | 12.82% |
| 2023 Q4 | 8.91 Billion KRW | 5.69% |
| 2023 Q1 | 8.86 Billion KRW | -51.9% |
| 2022 Q2 | 23.42 Billion KRW | -4.8% |
| 2022 FY | 18.43 Billion KRW | -23.9% |
| 2022 Q4 | 18.43 Billion KRW | -19.8% |
| 2022 Q3 | 22.98 Billion KRW | -1.88% |
| 2022 Q1 | 24.6 Billion KRW | 1.58% |
| 2021 Q3 | 24.4 Billion KRW | 0.0% |
| 2021 FY | 24.22 Billion KRW | -37.64% |
| 2021 Q4 | 24.22 Billion KRW | -0.74% |
| 2020 FY | 38.84 Billion KRW | -24.94% |
| 2019 FY | 51.74 Billion KRW | 9.69% |
| 2018 FY | 47.17 Billion KRW | 436.11% |
| 2017 FY | 8.79 Billion KRW | 458.64% |
| 2016 FY | 1.57 Billion KRW | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| HLB Pharmaceutical Co., Ltd | 53.19 Billion KRW | 83.235% |
| CMG Pharmaceutical Co., Ltd. | 40.02 Billion KRW | 77.72% |
| Celltrion Pharm, Inc. | 264.97 Billion KRW | 96.634% |
| Huons Global Co., Ltd. | 407.28 Billion KRW | 97.81% |
| DongKook Pharmaceutical Co., Ltd. | 263.36 Billion KRW | 96.613% |
| Enzychem Lifesciences Corporation | 16.91 Billion KRW | 47.285% |
| Humedix Co., Ltd. | 21.91 Billion KRW | 59.302% |
| Boditech Med Inc. | 30.48 Billion KRW | 70.744% |
| EuBiologics Co., Ltd. | 67.82 Billion KRW | 86.85% |
| Huons Co., Ltd. | 206.87 Billion KRW | 95.689% |
| BNC Korea Co., Ltd. | 21.94 Billion KRW | 59.36% |
| AptaBio Therapeutics Inc. | 38.19 Billion KRW | 76.647% |